Search by Drug Name or NDC
NDC 13845-1201-03 CYCLOSERINE 250 mg/250mg Details
CYCLOSERINE 250 mg/250mg
CYCLOSERINE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Parsolex Gmp Center, Inc.. The primary component is CYCLOSERINE.
Product Information
| NDC | 13845-1201 |
|---|---|
| Product ID | 13845-1201_f2a0c59a-f966-50f8-e053-2995a90a9cc1 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | CYCLOSERINE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | CYCLOSERINE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/250mg |
| Substance Name | CYCLOSERINE |
| Labeler Name | Parsolex Gmp Center, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA060593 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 13845-1201-03 (13845120103)
| NDC Package Code | 13845-1201-3 |
|---|---|
| Billing NDC | 13845120103 |
| Package | 40 CAPSULE in 1 BOTTLE (13845-1201-3) / 250 mg in 1 CAPSULE (13845-1201-1) |
| Marketing Start Date | 2009-03-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |